Analysis Tools
homeostasis/metabolism
|
• in mice treated with a high dose of CP 55,940 compared with similarly treated wild-type mice
|
|
• in mice fed a high-fat diet compared with similarly treated wild-type mice
|
|
• when fed a high-fat diet compared with similarly treated wild-type mice
|
|
• when fed a high-fat diet compared with similarly treated wild-type mice
|
|
• in fasted mice
|
|
• in fed and fasted mice
• in mice fed a high-fat diet
|
|
• in fasted mice
• in mice treated with poloxamer 407 (P407) to inhibit lipoprotein lipase activity
• in mice fed a high-fat diet
|
|
• in fasted mice
|
|
• forskolin-stimulated FA and glycerol release from white adipose tissue fat pads are decreased by compared to in wild-type mice
|
|
• modest as indicated by decreased circulating levels of glycerol, ketones, and triglycerides in a fasted state but normal circulating free fatty acid levels
|
|
• mice exhibit an increased tolerance to the hypometabolic activity (decreased locomotor activity and oxygen consumption) induced by a high dose of CP 55,940 compared with wild-type mice
|
behavior/neurological
|
• in mice treated with a high dose of CP 55,940 compared with similarly treated wild-type mice
|
|
• in mice treated with a high dose of CP 55,940 compared with similarly treated wild-type mice
|
growth/size/body
| N |
• whether fed standard chow or a high fat-diet, mice exhibit normal body weight, fat mass, and lean mass
|
liver/biliary system
|
• in fasted mice
|
